Prognosis of Early-onset Anorexia Nervosa

Sponsor
Assistance Publique - Hôpitaux de Paris
Study ID
NCT07311356
Status
Recruiting
Apply to this trial

Conditions

  • Anorexia Nervosa

Eligibility Criteria

Sex
ALL
Age
0 Years - 30 Years
Healthy Volunteers
Not accepted

Study Details

The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.

Key Dates

First listed
Dec 30, 2025
Start date
Dec 5, 2025
Status verified
Feb 2026
Primary completion
Mar 31, 2026
Completion
Mar 31, 2026

Study Design

Enrollment
140 participants (estimated)

Arms

  • Arm: Cohorte AM2P
    Completion of quality of life questionnaire, clinic

Primary Outcome Measure

Score of Eating Disorder Examination Questionnaire (EDE SQ) scale [ Time Frame: 6 months ]

Central Contacts

Related Studies